Want to join the conversation?
During 2Q16, in $CI's Global Health Care segment, premiums and fees increased 3% from 2Q15. In Global Supplemental Benefits, excluding FX, premiums and fees grew 12%, reflecting continued business growth. In the Group Disability and Life business, premiums and fees grew 3%, primarily driven by new sales.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?